Centessa Pharmaceuticals PLC

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, null, 184.86, 340.42, 961.26 ], "ebit_estimate": [ -201.42, -278.28, -186.49, 29.33, 514.96 ], "ebitda_estimate": [ -252.68, -290.65, -314.73, null, null ], "net_income_estimate": [ -244.56, -262.67, -237.82, -8.28, 474.2 ], "per_share_eps_estimate": [ -1.68, -1.75, -1.12, 0, 1.97 ], "eps_nri_estimate": [ -1.68, -1.75, -1.58, -0.03, 3.05 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 3.18, 3.16, 2.93, null, null ], "pretax_income_estimate": [ -243.65, -262.55, -153.98, 48.7, 521.28 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -49.4, -54.74, -56.88, null, null ], "gross_margin_estimate": [ null, null, 96, 94.75, 95.5 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 20250, 20.58 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": -15.03, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -6.48, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -5.5, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -10.22, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, null, null, null, null, null, null ], "ebit_estimate": [ -60.37, -64.18, -64.02, -69.8, -69.65, -71.4, -71.85 ], "ebitda_estimate": [ -69.58, -70.86, null, null, null, null, null ], "net_income_estimate": [ -59.67, -63.23, -62.72, -71.25, -71.1, -72.85, -73.3 ], "per_share_eps_estimate": [ -0.41, -0.43, -0.43, -0.43, -0.43, -0.43, -0.43 ], "eps_nri_estimate": [ -0.41, -0.43, -0.43, -0.45, -0.44, -0.45, -0.45 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -59.42, -62.9, -62.38, -71.25, -71.1, -72.85, -73.3 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": -15.03, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -6.48, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -5.5, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -10.22, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }